Delivery Order SPE2DX22D0010-SPE2D825FHC49
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Zenzedi tablets 30mg, a pharmaceutical product used in attention deficit disorder treatment. This firm fixed-price delivery order, valued at $6.7K, represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Zenzedi tablets 20mg, with a ceiling value of $5,259.00. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is set for ultimate completion by August 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Zenzedi Tabs 30mg with a ceiling value of $1,883.91. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award was made competitively with no set-aside designation, leveraging the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,272.74 to AmerisourceBergen Drug Corp for Zenzedi 15 mg tablets (30-count supply) with a firm fixed price and ultimate completion date of September 2, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026. The...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an agency within the Department of Defense. The $2,645.92 firm fixed-price delivery order contract is for the supply of Zenzedi 20mg tablets, a pharmaceutical product. The contract has an ultimate completion date of May 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency Troop Support Medical awarded a $185,070 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561500641 Zenzedi tablets. Under this order, Amerisourcebergen will deliver 30mg Zenzedi tablets to a location in Conshohocken, Pennsylvania by July 17, 2023 to support the Defense Logistics Agency's medical supply needs. As a top tier medical product supplier, Amerisourcebergen will fulfill this delivery order from its corporate headquarters...
- This contract award, SPE2DX22D0010|SPE2D825FBJ27, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,371.59 firm-fixed-price delivery order is for Zenzedi (dextroamphetamine sulfate) 20mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $394,260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561662684 ZENZEDI 15 MG TABLET 30S. As the prime contractor, Amerisourcebergen will deliver this pharmaceutical product to a location in Conshohocken, Pennsylvania by August 1, 2023 in support of the Defense Logistics Agency's medical supply chain operations. No set aside designation or subcontractors were identified for this order issued under an existing DLA pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,527.76 contract is for the delivery of ZENZEDI TABS 20MG, a pharmaceutical product, to support DLA Troop Support Medical programs and facilities. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that provides a range of pharmaceutical products and medical supplies...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,521.90 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. The delivery order, issued under a firm fixed price contract type, covers the supply of ADZENYS XR ODT Tablets 1's 6.3MG, a prescription medication used in the treatment of attention-deficit/hyperactivity disorder....
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHC49Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,057.66 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Zenzedi Tablets 15mg, a pharmaceutical product for attention-deficit/hyperactivity disorder treatment. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and carries an ultimate completion date of July 23, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military healthcare systems, the Defense Health Agency, and other government healthcare organizations. The broader IDC vehicle enables the company to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, demonstrating the contractor's capability to meet complex federal medical supply demands through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/22/25 |